Palivizumab Prophylaxis among Infants at Increased Risk of Hospitalization due to Respiratory Syncytial Virus Infection in UAE: A Hospital-Based Study.

Mahmoud ElHalikK El-AtawiS K DashA FaquihA D SatyanN GourshettiwarA KhanS VarugheseA RameshE Khamis

Published in: Canadian respiratory journal (2019)

This study demonstrated that palivizumab prophylaxis in children at high risk of developing RSV infection was effective in reducing the risk of hospitalization with a high compliance rate over the five RSV seasons.

Keyphrases

respiratory syncytial virus
healthcare
young adults
acute care
adverse drug